{
    "eid": "2-s2.0-85113253707",
    "title": "Tenofovir alafenamide nephrotoxicity: a case report and literature review",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Virology",
            "@code": "2406",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Acute kidney injury",
        "Antiretroviral therapy",
        "Case report",
        "HIV",
        "Mitochondria",
        "Nephrotoxicity",
        "Renal pathology",
        "Tenofovir alafenamide"
    ],
    "authors": [
        "Thornthun Ueaphongsukkit",
        "Sivaporn Gatechompol",
        "Anchalee Avihingsanon",
        "Jerasit Surintrspanont",
        "Kroonpong Iampenkhae",
        "Yingyos Avihingsanon",
        "Suwasin Udomkarnjananun"
    ],
    "citedby-count": 3,
    "ref-count": 36,
    "ref-list": [
        "Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?",
        "Tenofovir nephrotoxicity: 2011 update",
        "Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society-USA panel",
        "EACS Governing Board. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0",
        "Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report",
        "Fanconi syndrome and tenofovir alafenamide: a case report",
        "Overdose of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in an HIV-1-infected subject with attempted suicide",
        "Acute kidney injury in a patient on tenofovir alafenamide fumarate after initiation of treatment for hepatitis C virus infection",
        "Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: a case report",
        "Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities",
        "Clinical pharmacology in HIV therapy",
        "Tenofovir alafenamide: a novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus",
        "Brief report: switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected adults with renal impairment: 96-week results from a single-arm, multicenter, open-label phase 3 study",
        "Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials",
        "Is Tenofovir alafenamide safer than tenofovir disoproxil fumarate for the kidneys?",
        "Urine assay to measure tenofovir concentrations in patients taking tenofovir alafenamide",
        "Lower urine tenofovir concentrations among individuals taking tenofovir alafenamide versus tenofovir disoproxil fumarate: implications for point-of-care testing",
        "Pharmacokinetics and safety of tenofovir alafenamide in HIV-uninfected subjects with severe renal impairment",
        "Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure",
        "Cumulative exposure of TDF is associated with kidney tubulopathy whether it is currently used or discontinued",
        "A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects",
        "Renal effects of novel antiretroviral drugs",
        "Clinical benefits of using inulin clearance and cystatin C for determining glomerular filtration rate in HIV-1-infected individuals treated with dolutegravir",
        "Evaluation of serum creatinine changes with integrase inhibitor use in human immunodeficiency virus-1 infected adults",
        "Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection",
        "Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study",
        "Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study",
        "Dolutegravir plus two different prodrugs of tenofovir to treat HIV",
        "Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey",
        "Worldwide distribution of glomerular diseases: the role of renal biopsy registries",
        "Immunoglobulin a nephropathy and IgA vasculitis (Henoch-Sch\u00f6nlein Purpura)",
        "Prognosis in IgA nephropathy: 30-year analysis of 1012 patients at a single center in Japan",
        "Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors",
        "The MEST score provides earlier risk prediction in lgA nephropathy",
        "The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification",
        "Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarate"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "C2F",
        "Second Century Fund",
        "Chulalongkorn University"
    ]
}